NL-OMON22939
Recruiting
Not Applicable
A new approach to determine the time of incidence of traumatic brain injury
Amsterdam University Medical Centers location AMC Meibergdreef 9 1105 AZ Amsterdam0 sites25 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Amsterdam University Medical Centers location AMC Meibergdreef 9 1105 AZ Amsterdam
- Enrollment
- 25
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years or older;
- •the patients, or their legal representative, have signed an informed consent;
- •have a traumatic subacute or chronic SDH;
- •the date of trauma must be known
Exclusion Criteria
- •recurrent SDH;
- •previous surgery for SDH in the past 365 days;
- •inability to obtain informed consent from the patient (or when the patient has a depressed level of consciousness their legal representative), including language barrier.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A new approach to determine the time of incidence of traumatic brain injury with chronic subdural hematomas.traumatisch hersenletselChronic Subdural Hematomas - Traumatic Brain Injury10007963NL-OMON42525Academisch Medisch Centrum15
Not yet recruiting
Phase 4
Comparison of effects of dexmedetomidine added to levobupivacaine and recemic bupivacaine for cesarean section under spinal anaesthesia.CTRI/2023/09/057280Rajendra Insitute of Medical Sciences, Ranchi
Completed
Not Applicable
A new approach to determine the age of (sub)acute and chronic subdural hematomasNL-OMON50105Academisch Medisch Centrum25
Active, not recruiting
Not Applicable
The determination of the exact time of administration of Lantus basal insulin for treating type 2 diabetes mellitus patients poorly controlled with basal insulin associated with oral antidiabetic drugsType 2 diabetes mellitusEUCTR2005-002958-21-HUSanofi-Synthelabo Rt.
Completed
Not Applicable
Quantitative analysis of onset timing of interstitial lung disease during treatment with biologicsRheumatoid arthritisJPRN-UMIN000015358Drug Development and Regulatory Science, Faculty of Pharmacy Keio University20